Screening and Management of Depression in Patients With Cardiovascular Disease: JACC State-of-the-Art Review

MK Jha, A Qamar, M Vaduganathan… - Journal of the American …, 2019 - jacc.org
Depression is a common problem in patients with cardiovascular disease (CVD) and is
associated with increased mortality, excess disability, greater health care expenditures, and …

Combining antidepressants vs antidepressant monotherapy for treatment of patients with acute depression: a systematic review and meta-analysis

J Henssler, D Alexander, G Schwarzer, T Bschor… - JAMA …, 2022 - jamanetwork.com
Importance Combining antidepressants is frequently done in the treatment of acute
depression, but studies have yielded conflicting results. Objective To conduct a systematic …

Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): a single-blind, parallel-group, randomised …

D Freeman, BS Loe, LM Yu, J Freeman… - The Lancet Public …, 2021 - thelancet.com
Background The effectiveness of the COVID-19 vaccination programme depends on mass
participation: the greater the number of people vaccinated, the less risk to the population …

Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions

RS McIntyre, M Alsuwaidan, BT Baune, M Berk… - World …, 2023 - Wiley Online Library
Treatment‐resistant depression (TRD) is common and associated with multiple serious
public health implications. A consensus definition of TRD with demonstrated predictive utility …

[HTML][HTML] Antidepressant augmentation versus switch in treatment-resistant geriatric depression

EJ Lenze, BH Mulsant, SP Roose… - … England Journal of …, 2023 - Mass Medical Soc
Background The benefits and risks of augmenting or switching antidepressants in older
adults with treatment-resistant depression have not been extensively studied. Methods We …

Pharmacological treatments for patients with treatment-resistant depression

VL Ruberto, MK Jha, JW Murrough - Pharmaceuticals, 2020 - mdpi.com
Over a third of patients with major depressive disorder (MDD) do not have an adequate
response to first-line antidepressant treatments, ie, they have treatment-resistant depression …

Effect of repetitive transcranial magnetic stimulation on treatment-resistant major depression in US veterans: a randomized clinical trial

JA Yesavage, JK Fairchild, Z Mi, K Biswas… - JAMA …, 2018 - jamanetwork.com
Importance Treatment-resistant major depression (TRMD) in veterans is a major clinical
challenge given the high risk for suicidality in these patients. Repetitive transcranial …

Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression

F Scott, E Hampsey… - Journal of …, 2023 - journals.sagepub.com
Background: Major depressive disorder (MDD) is a highly burdensome health condition, for
which there are numerous accepted pharmacological and psychological interventions …

Pharmacotherapies for treatment-resistant depression: how antipsychotics fit in the rapidly evolving therapeutic landscape

MK Jha, SJ Mathew - American Journal of Psychiatry, 2023 - Am Psychiatric Assoc
One in three adults with major depressive disorder (MDD) do not experience clinically
significant improvement after multiple sequential courses of antidepressants and have …

The cardiovascular effects of newer antidepressants in older adults and those with or at high risk for cardiovascular diseases

LM Behlke, EJ Lenze, RM Carney - CNS drugs, 2020 - Springer
Depression is common in older adults and those with cardiovascular disease. Although
selective serotonin reuptake inhibitors generally have been shown to be safe to treat …